Related Experiment Video
Updated: Feb 4, 2026

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
Published on: May 9, 2025
18F-DOPA-PET and Advanced MRI Improve Treatment Response Assessment in IDH1/2-Mutant Gliomas Treated with IDH
Diego Prost1,2, Lucia Nichelli1,3, Laura Rozenblum4,5
1Inserm, CNRS, UMR S 1127, Paris Brain Institute, Sorbonne University, Paris, France.
Purpose:
Small-molecule inhibitors targeting isocitrate dehydrogenase (IDH) 1/2-mutant proteins have demonstrated benefit in IDH1/2-mutant gliomas. However, responses assessed by conventional MRI measurements are infrequent, delayed, and difficult to interpret, highlighting the need for early biomarkers of treatment benefit. In this study, we investigated 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine positron emission tomography (18F-DOPA-PET) and MRI responses in patients with IDH1/2-mutant glioma receiving IDH inhibitors (IDHi).
Experimental Design:
Patients with IDH1/2-mutant glioma receiving IDHi as part of trials or expanded access programs with pre- and posttreatment MRI and 18F-DOPA-PET were included. Evaluations included 2D/3D measurements on T2-weighted fluid-attenuated inversion recovery images; T1-post-contrast, perfusion, and diffusion imaging for MRI; and metabolic tumor volume (MTV), total lesion glycolysis, and tumor-to-background ratios (TBR) for 18F-DOPA-PET. Disease response evaluation using volumetric assessments, RANO 2.0, and PET RANO 1.0 criteria were compared and correlated with outcomes.
Results:
From 2021 to 2025, 20 patients with IDH1/2-mutant glioma (8 with astrocytoma and 12 with oligodendroglioma) receiving IDHi (4 receiving ivosidenib and 16 receiving vorasidenib) were analyzed. Significant reductions in 18F-DOPA-PET parameters including TBRmean, TBRmax, and MTV were observed in 10 of 20 patients, aligning with observed changes in perfusion and diffusion imaging. Nine partial responses and one complete response were identified using 18F-DOPA-PET, whereas both volumetric and standard 2D morphologic MRI assessments indicated stable disease as best response. PET response on MTV was correlated with prolonged tumor control.
Conclusions:
These results highlight the potential of 18F-DOPA-PET and advanced MRI sequences as valuable complements to standard RANO 2.0 MRI evaluations for assessing treatment response in patients with glioma undergoing IDHi therapy.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Extraction: Advanced Methods
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...

